Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (761-770 of 850) with videos related to

Pageof 85
Sort By:
World Journal of Urology|January 19, 2026
Development and external validation of a nomogram predicting cancer-specific mortality-free survival after trimodal therapy in muscle-invasive bladder cancerMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
Annals of Surgical Oncology|December 10, 2024
Urinary Diversion Versus Adverse In-Hospital Outcomes After Radical CystectomyNatali Rodriguez Peñaranda, Francesco di Bello, Andrea Marmiroli, et al.
Diagnostic Pathology|May 3, 2019
SNW1 is a prognostic biomarker in prostate cancerDoris Höflmayer, Carla Willich, Claudia Hube-Magg, et al.
The Journal of Urology|January 16, 2007
Development and external validation of an extended repeat biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
Annals of Surgical Oncology|May 17, 2026
Years of Life Lost in Patients with Muscle-Invasive and Metastatic Bladder CancerMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
International Journal of Molecular Sciences|February 2, 2017
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate CancerNathaniel Melling, Masoud Rashed, Cornelia Schroeder, et al.
Journal of Surgical Oncology|March 28, 2025
Robot-Assisted Versus Open Radical Cystectomy: Comparison of Adverse In-Hospital OutcomesFrancesco Di Bello, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
Urologic Oncology|March 9, 2025
Cirrhosis and liver disease vs. adverse in-hospital outcomes after radical prostatectomyFabian Falkenbach, Natali Rodriguez Peñaranda, Mattia Longoni, et al.
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Carcinogenesis|October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomyMaria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
Pageof 85

Showing results (761-770 of 850) with videos related to

Sort By:
Pageof 85
World Journal of Urology|January 19, 2026
Development and external validation of a nomogram predicting cancer-specific mortality-free survival after trimodal therapy in muscle-invasive bladder cancerMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
Annals of Surgical Oncology|December 10, 2024
Urinary Diversion Versus Adverse In-Hospital Outcomes After Radical CystectomyNatali Rodriguez Peñaranda, Francesco di Bello, Andrea Marmiroli, et al.
Diagnostic Pathology|May 3, 2019
SNW1 is a prognostic biomarker in prostate cancerDoris Höflmayer, Carla Willich, Claudia Hube-Magg, et al.
The Journal of Urology|January 16, 2007
Development and external validation of an extended repeat biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
Annals of Surgical Oncology|May 17, 2026
Years of Life Lost in Patients with Muscle-Invasive and Metastatic Bladder CancerMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
International Journal of Molecular Sciences|February 2, 2017
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate CancerNathaniel Melling, Masoud Rashed, Cornelia Schroeder, et al.
Journal of Surgical Oncology|March 28, 2025
Robot-Assisted Versus Open Radical Cystectomy: Comparison of Adverse In-Hospital OutcomesFrancesco Di Bello, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
Urologic Oncology|March 9, 2025
Cirrhosis and liver disease vs. adverse in-hospital outcomes after radical prostatectomyFabian Falkenbach, Natali Rodriguez Peñaranda, Mattia Longoni, et al.
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Carcinogenesis|October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomyMaria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
Pageof 85